EP3109258
RECOMBINANT RSV ANTIGENS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.12.2008EP published:
23.1.2019EP application number:
16180926.4
EPO information:
European Patent Register
Max expiry date:
22.12.2028
Title:
RECOMBINANT RSV ANTIGENS
Timeline
Today
23.12.2008EP application
23.1.2019EP Publication
Owner
Name:
ID Biomedical Corporation of QuebecAddress:
2323 Boul. du Parc Technologique Ste Foy, Quebec G1P 4R8, CA
Name:
GlaxoSmithKline Biologicals s.a.Address:
rue de l'Institut 89, 1330, Rixensart, BE
Inventor
Name:
BAUDOUX, Jean-PierreAddress:
Rixensart, BE
Name:
BLAIS, NormandAddress:
Laval, Québec H6V 3S8, CA
Name:
RHEAULT, PatrickAddress:
Laval, Québec H7V 3S8, CA
Name:
RUELLE, Jean-LoiusAddress:
Rixensart, BE
Priority
Number:
16524 PDate:
24.12.2007Country:
US
Number:
56206 PDate:
27.5.2008Country:
US
Classification
Categories:
C07K 19/00, A61K 39/00, A61K 39/155, A61K 39/295, A61K 9/107, A61K 9/127, A61P 31/14, A61P 37/04, C07K 14/135, C12N 15/45, C12N 15/62, C07K 14/005, A61K 39/12